Suormala Terttu, Baumgartner Matthias R, Coelho David, Zavadakova Petra, Kozich Viktor, Koch Hans Georg, Berghaüser Martin, Wraith James E, Burlina Alberto, Sewell Adrian, Herwig Jürgen, Fowler Brian
Metabolic Unit, University Children's Hospital, Römergasse 8, CH-4058 Basel, Switzerland.
J Biol Chem. 2004 Oct 8;279(41):42742-9. doi: 10.1074/jbc.M407733200. Epub 2004 Aug 2.
Intracellular cobalamin is converted to adenosylcobalamin, coenzyme for methylmalonyl-CoA mutase and to methylcobalamin, coenzyme for methionine synthase, in an incompletely understood sequence of reactions. Genetic defects of these steps are defined as cbl complementation groups of which cblC, cblD (described in only two siblings), and cblF are associated with combined homocystinuria and methylmalonic aciduria. Here we describe three unrelated patients belonging to the cblD complementation group but with distinct biochemical phenotypes different from that described in the original cblD siblings. Two patients presented with isolated homocystinuria and reduced formation of methionine and methylcobalamin in cultured fibroblasts, defined as cblD-variant 1, and one patient with isolated methylmalonic aciduria and deficient adenosylcobalamin synthesis in fibroblasts, defined as cblD-variant 2. Cell lines from the cblD-variant 1 patients clearly complemented reference lines with the same biochemical phenotype, i.e. cblE and cblG, and the cblD-variant 2 cell line complemented cells from the mutant classes with isolated deficiency of adenosylcobalamin synthesis, i.e. cblA and cblB. Also, no pathogenic sequence changes in the coding regions of genes associated with the respective biochemical phenotypes were found. These findings indicate heterogeneity within the previously defined cblD mutant class and point to further complexity of intracellular cobalamin metabolism.
细胞内钴胺素通过一系列尚未完全明确的反应转化为腺苷钴胺素(甲基丙二酰辅酶A变位酶的辅酶)和甲基钴胺素(甲硫氨酸合成酶的辅酶)。这些步骤的基因缺陷被定义为钴胺素(cbl)互补组,其中cblC、cblD(仅在两名同胞中描述)和cblF与同型胱氨酸尿症和甲基丙二酸尿症合并症相关。在此,我们描述了三名属于cblD互补组但具有与最初描述的cblD同胞不同的独特生化表型的无亲缘关系患者。两名患者表现为孤立性同型胱氨酸尿症,培养的成纤维细胞中甲硫氨酸和甲基钴胺素形成减少,定义为cblD变异型1;一名患者表现为孤立性甲基丙二酸尿症,成纤维细胞中腺苷钴胺素合成不足,定义为cblD变异型2。来自cblD变异型1患者的细胞系明显与具有相同生化表型的参照系互补,即cblE和cblG,而cblD变异型2细胞系与腺苷钴胺素合成孤立缺陷的突变类细胞互补,即cblA和cblB。此外,在与各自生化表型相关的基因编码区未发现致病序列变化。这些发现表明在先前定义的cblD突变类中存在异质性,并指出细胞内钴胺素代谢的进一步复杂性。